Literature DB >> 8761415

Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy.

W Bursch1, A Ellinger, H Kienzl, L Török, S Pandey, M Sikorska, R Walker, R S Hermann.   

Abstract

Active cell death in hormone-dependent cells was studied using cultured human mammary carcinoma cells (MCF-7) treated with the anti-estrogens (AEs) tamoxifen (TAM), 4-hydroxy-tamoxifen (OH-TAM) or ICI 164 384 (10(-8)-10(-5) M) as a model. The following results were obtained. (i) In untreated MCF-7 cells a wave of replication occurred in the first 5 days of culture. All three AEs caused a dose-dependent inhibition of cell replication. (ii) TAM and OH-TAM at 10(-5) M, but not ICI 164 384, caused lytic cell death (necrosis) within 24 h, which was not inhibited by estradiol (10(-9)-10(-6)M). (iii) Lower concentrations of TAM or OH-TAM (up to 10(-6) M) or ICI 164 384 induced a more gradual appearance of cell death beginning at day 3. This type of cell death was inhibited by estradiol (10(-9) M), indicating its active nature. (iv) Nuclei showed two distinct patterns of alteration: (a) apoptosis-like condensation and fragmentation of chromatin to crescent masses abutting the nuclear envelope; (b) condensation of the chromatin to a single, pyknotic mass in the center of the nucleus, detached from the nuclear envelope. Quantitative histological evaluation revealed the predominance of pyknosis. (v) Biochemical DNA analysis revealed that only a relatively small amount of the total DNA was finally degraded into low molecular weight fragments (20 kb and less). (vi) Active cell death, with both apoptotic and pyknotic nuclear morphology, was associated with extensive formation of autophagic vacuoles (AV).3-Methyladenine, a known inhibitor of AV formation, partially prevented cell death as detected by nuclear changes. (vii) ICI 164 384 was about 10 times more effective than TAM or OH-TAM at inhibiting DNA synthesis, but had equal potency in inducing active cell death. It is concluded that AEs have anti-proliferative and anti-survival effects on MCF-7 human mammary cancer cells in culture. These two effects are under separate control because they differ by kinetics, dose dependence and sensitivity to the various AEs. Active cell death in MCF-7 cells seems to be initiated by autophagy, in contrast to concepts of apoptosis, and thus corresponds to autophagic/ lysosomal or type II death as previously defined. This may be important because of biochemical and molecular differences between these various subtypes of active cell death.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8761415     DOI: 10.1093/carcin/17.8.1595

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  175 in total

1.  Convergence of multiple autophagy and cytoplasm to vacuole targeting components to a perivacuolar membrane compartment prior to de novo vesicle formation.

Authors:  John Kim; Wei-Pang Huang; Per E Stromhaug; Daniel J Klionsky
Journal:  J Biol Chem       Date:  2001-10-23       Impact factor: 5.157

Review 2.  Regulation and function of autophagy during cell survival and cell death.

Authors:  Gautam Das; Bhupendra V Shravage; Eric H Baehrecke
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-06-01       Impact factor: 10.005

3.  Blocking NF-κB nuclear translocation leads to p53-related autophagy activation and cell apoptosis.

Authors:  Bao-Song Zhu; Chun-Gen Xing; Fang Lin; Xiao-Qing Fan; Kui Zhao; Zheng-Hong Qin
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

4.  Dual functions of autophagy in the response of breast tumor cells to radiation: cytoprotective autophagy with radiation alone and cytotoxic autophagy in radiosensitization by vitamin D 3.

Authors:  Molly L Bristol; Xu Di; Matthew J Beckman; Eden N Wilson; Scott C Henderson; Aparna Maiti; Zhen Fan; David A Gewirtz
Journal:  Autophagy       Date:  2012-04-13       Impact factor: 16.016

5.  Autophagy: a cyto-protective mechanism which prevents primary human hepatocyte apoptosis during oxidative stress.

Authors:  Ricky H Bhogal; Christopher J Weston; Stuart M Curbishley; David H Adams; Simon C Afford
Journal:  Autophagy       Date:  2012-04-01       Impact factor: 16.016

Review 6.  Autophagy in cell death: an innocent convict?

Authors:  Beth Levine; Junying Yuan
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

7.  A lipid-modified estrogen derivative that treats breast cancer independent of estrogen receptor expression through simultaneous induction of autophagy and apoptosis.

Authors:  Sutapa Sinha; Sayantani Roy; Bathula Surendar Reddy; Krishnendu Pal; Godeshala Sudhakar; Seethalakshmi Iyer; Shamit Dutta; Enfeng Wang; Pawan Kumar Vohra; Karnati Rammohan Roy; Pallu Reddanna; Debabrata Mukhopadhyay; Rajkumar Banerjee
Journal:  Mol Cancer Res       Date:  2011-02-02       Impact factor: 5.852

8.  Dissociation of vitamin D3 and anti-estrogen mediated growth regulation in MCF-7 breast cancer cells.

Authors:  E Nolan; M Donepudi; K VanWeelden; L Flanagan; J Welsh
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

Review 9.  The mechanisms of brain ischemic insult and potential protective interventions.

Authors:  Zhao-Hui Guo; Feng Li; Wei-Zhi Wang
Journal:  Neurosci Bull       Date:  2009-06       Impact factor: 5.203

10.  Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.

Authors:  Robert Clarke; Ayesha N Shajahan; Rebecca B Riggins; Younsook Cho; Anatasha Crawford; Jianhua Xuan; Yue Wang; Alan Zwart; Ruchi Nehra; Minetta C Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2009-03       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.